UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 22,
Protagonist Therapeutics (NASDAQ:PTGX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Protagonist Therapeutics Charts.
Protagonist Therapeutics (NASDAQ:PTGX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Protagonist Therapeutics Charts.

Protagonist Therapeutics, Inc News

Turnstone Biologics Appoints William Waddill to its Board of Directors
Tuesday 16 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 144 - Report of proposed sale of securities
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 144 - Report of proposed sale of securities
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 144 - Report of proposed sale of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 19 January 2024 (4 months ago) • Edgar (US Regulatory)

More Protagonist Therapeutics, Inc News Articles